Eagle Pharmaceuticals Inc
Teva Stock Could Jump after Good News from Partner Manufacturers
Eagle Pharmaceuticals, one of Teva’s partners, won a lawsuit against the FDA for not granting orphan drug status to Bendeka.
XBI Holdings Finished Strong as Market Bounced Back on April 13
On April 13, 2016, the SPDR S&P Biotech ETF (XBI) gained 2.4% for the day. XBI outperformed the SPDR S&P 500 ETF (SPY), which gave a return of 1.1%.